期 |
栏目 |
标题 |
文件 |
卷 28, 编号 5 (2022) |
Reviews |
Klotho protein and atherosclerotic cardiovascular diseases: prolonging the thread of life |
(Rus)
|
卷 29, 编号 3 (2023) |
Reviews |
Chemerin as a cardiovascular biological marker: Present and future |
(Rus)
|
卷 29, 编号 1 (2023) |
Reviews |
Coronary heart disease in patients with human immunodeficiency virus infection |
(Rus)
|
卷 29, 编号 2 (2023) |
Reviews |
Diagnostic and therapeutic aspects of neuregulin-1: A review |
(Rus)
(Eng)
|
卷 29, 编号 4 (2023) |
Reviews |
Current insights into the role of miRNA-125 in cardiovascular disease: potential biological markers and therapeutic targets |
(Rus)
|
卷 29, 编号 5 (2023) |
Reviews |
Relaxin as a biological marker and therapeutic target in heart failure |
(Rus)
|
卷 28, 编号 6 (2022) |
Reviews |
miRNA-122 as a new player in cardiovascular disease |
(Rus)
|
卷 30, 编号 1 (2024) |
Reviews |
Diagnostic, prognostic and therapeutic aspects of apelin in cardiovascular diseases |
|
卷 30, 编号 3 (2024) |
Case reports |
A clinical case of isolated non-compact left ventricular myocardium in a 29-year-old patient |
|